alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

Annual Report Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
for the fiscal year ended December 31, 1999

Commission File Number: 33-49129-03

Structured Asset Securities Corporation issuer in respect of
Commercial Mortgage Pass-Through Certificates Series 1999-C2
(Exact Name of registrant as specified in its charter)

Delaware      			74-2440858
(State or Other Juris-		(I.R.S. Employer
diction of Incorporation)     Identification No.)

220 Vessy Street, 20th Floor, New York, NY 10285
(Address of Principal Executive Office)

212-526-5594
(Registrant's telephone number, including area code)


Securities registered pursuant to Section 12(b) of the
Act:     None

Securities registered pursuant to Section 12(g) of the
Act:     None

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed  by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes  X   No _

Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not contained herein,
and will not be contained, to the best of registrant's
knowledge, in definitive proxy or information statements
incorporated by reference in part III of this Form 10-K or any
amendment to this Form 10-K.

Not applicable.

Aggregate market value of voting stock held by non-affiliates of
the Registrant as of December 31, 1999.

Not applicable.

Number of shares of common stock outstanding as of December 31,
1999.

Not applicable.
Case 1:07-cv-03493-CM Document 12 Filed 09/06/2007 Page 1 of 1
#### GRADING CO. v. CONSTRUCTION CO.

No. 31 PC.

Case below: 27 N.C. App. 725.

Petition for discretionary review under G.S. 7A-31 denied 3 February 1976.
**Exhibit 10.3**
[DELOITTE & TOUCHE LETTERHEAD]   Date ReferenceApril 17, 2003 A. Sandler
INDEPENDENT AUDITORS’ CONSENT
We consent to the incorporation in ASM International N.V.’s RegistrationStatements no.’s 33-6184, 33-6185, 33-6186, 33-78628 and 33-93026 on Form S-8and no. 333-92006, 333-8080 and 333-11502 on Form F-3 of our report datedFebruary 17,2003, on the consolidated financial statements of ASM International N.V., whichare included in this annual report on Form 20-F of ASM International N.V., forthe year ended December 31, 2002.
/s/ Deloitte & Touche Accountants
UbirTED STATES DISTRICT COURT O1 Cv ' 3258 

SOUTHERN DISTRICT OF NEW YORK 

ARMAND CORLEW, et al., 

Defendants. 

RULE 7.1 STATEMENT OF MONSANTO COMPANY, 

PHARMACIA CORPORATION AND GENERAL ELECTRIC COMPANY 

Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, the undersigned 

counsel certifies that Defendant Pharmacia Corporation is a wholly-owned subsidiary of Pfizer, 

Inc., and that Defendant Monsanto Company has no parent company and that no publicly owned 

company owns more than 10% of its stock. 

Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, the undersigned 

counsel certifies that Defendant General Electric Company has no parent company and no 

publicly owned entity owns more than 10% of its stock. 

Dated: New York, New York 

April 23,2007 LEADER & BERKON LLP 

630 Third Avenue, 1 7th l lo or 

New York, New York 1 00 1 7 

(2 12) 486-2400 

Case 1:07-cv-03258-VM Document 2 Filed 04/23/2007 Page 1 of 2
Thomas M. Carney 

Kenneth R. Heineman 

Carol A. Rutter 

Adam Miller 

Mark G. Arnold 

HUSCH & EPPENBERGER, LLP 

The Plaza in Clayton Office Tower 

190 Carondelet Plaza, Suite 600 

St. Louis, MO 63105 

(3 14) 480-1500 

Attorneys for Defendants Monsanto 

Company and Pharmacia Corporation 

BOND, SCHOENECK & KING, PLLC 

By: Is1 

ARTHUR J. SIEGEL (AS-5 1 8 1) 

1 1 1 Washington Avenue 

Albany, New York 122 10 

(5 1 8) 533-3000 

Attorneys for Defendant General 

Electric Company 

To: Lawrence P. Biondi, Esq. 

Law Offices of Lawrence P. Biondi 

8 1 Main Street, Suite 504 

White Plains, NY 1060 1 

Attorneys for Plaintzfls 

Case 1:07-cv-03258-VM Document 2 Filed 04/23/2007 Page 2 of 2
II 

116TH CONGRESS 

1ST SESSION S. 1654 

To amend the Internal Revenue Code of 1986 to provide authority to add 

additional vaccines to the list of taxable vaccines. 

IN THE SENATE OF THE UNITED STATES 

MAY 23 (legislative day, MAY 22), 2019 

Mr. CASEY (for himself, Mr. ISAKSON, Mr. MENENDEZ, Mr. PORTMAN, Mr. 

CARDIN, and Mr. CASSIDY) introduced the following bill; which was read 

twice and referred to the Committee on Finance 

A BILL 

To amend the Internal Revenue Code of 1986 to provide 

authority to add additional vaccines to the list of taxable 

vaccines. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Vaccine Access Im5 provement Act of 2019’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•S 1654 IS

1 SEC. 2. ADDITION OF NEW VACCINES TO LIST OF TAXABLE 

2 VACCINES. 

3 (a) IN GENERAL.—Section 4132(a)(1) of the Internal 

4 Revenue Code of 1986 is amended by adding at the end 

5 the following new subparagraph: 

6 ‘‘(Q) Any vaccine which is not described in 

7 any other subparagraph of this paragraph and 

8 which is included on the Vaccine Injury Table 

9 under section 2114 of the Public Health Service 

10 Act.’’. 

11 (b) NOTIFICATION.—Not later than 30 days after the 

12 Secretary of Health and Human Services adds a vaccine 

13 to the Vaccine Injury Table pursuant of section 2114 of 

14 the Public Health Service Act (42 U.S.C. 300aa–14), the 

15 Secretary shall notify the Secretary of the Treasury, the 

16 Committee on Health, Education, Labor, and Pensions of 

17 the Senate, the Committee on Finance of the Senate, the 

18 Committee on Energy and Commerce of the House of 

19 Representatives, and the Committee on Ways and Means 

20 of the House of Representatives of such designation. 

21 (c) EFFECTIVE DATE.— 

22 (1) SALES, ETC.—The amendment made by 

23 subsection (a) shall apply to sales and uses on or 

24 after the date on which the Secretary of Health and 

25 Human Services lists any new vaccine pursuant to 

26 section 2114 of the Public Health Service Act (42 


kjohnson on DSK79L0C42 with BILLS
3 

•S 1654 IS

1 U.S.C. 300aa–14) for purposes of compensation for 

2 any vaccine-related injury or death through the Vac3 cine Injury Compensation Trust Fund. 

4 (2) DELIVERIES.—For purposes of paragraph 

5 (1) and section 4131 of the Internal Revenue Code 

6 of 1986, in the case of sales on or before the effec7 tive date described in such paragraph for which de8 livery is made after such date, the delivery date shall 

9 be considered the sale date. 

Æ 


kjohnson on DSK79L0C42 with BILLS
#### IN RE BULLARD

No. 57.

Case below: 22 N.C. App. 245.

. Motion of Attorney General to dismiss appeal for lack of substantial constitutional question allowed 24 September, 1974.
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the annual report of Community Trust Bancorp, Inc. (“CTBI”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jean R. Hale, Chairman, President and Chief Executive Officer of CTBI, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of CTBI.





/s/ Jean R. Hale


Jean R. Hale


Chairman, President and CEO


March 15, 2011
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 18

- 20187 Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff

- Appellee

v.
MANUEL MUNOZ

- BETANCUR, also known as Jesus Sanchez

- Alvarez , Defendant

- Appellant

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:17

- CR

- 665

- 1

Before HIGGINBOTHAM, SMITH, and HAYNES, Circuit Judges.
PER CURIAM: *
The Federal Public Defender appointed to represent Manuel Munoz

Betancur has moved for leave to withdraw and has filed a brief in accordance
with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Munoz

- Betancur h a s not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED October 22, 2018

Lyle W. Cayce Clerk Case: 18-20187 Document: 00514691717 Page: 1 Date Filed: 10/22/2018No. 18

- 20187

2 nonfrivolous issue for appellate review. Accor dingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 TH C IR

. R. 42.2. Case: 18-20187 Document: 00514691717 Page: 2 Date Filed: 10/22/2018
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group; NHLBI Institutional Training Mechanism Review Committee.                    

*Date:*                         November 15-16, 2007.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Admiral Fell Inn, 888 South Broadway, Baltimore, MD 21231.                    

*Contact Person:*                         Charles Joyce, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892-7924, 301-435-0288,                         *cjoyce@nhlbi.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) 

Dated: September 28, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-4920 Filed 10-3-07; 8:45 am]

BILLING CODE 4140-01-M
Case 1:07-cv-03345-RJS Document 27-31 Filed 07/31/2008 Page 1 of 2
Case 1:07-cv-03345-RJS Document 27-31 Filed 07/31/2008 Page 2 of 2
#### UTILITIES COMM v. POWER CO.

No. 54 PC

Case below: 48 NC App 453

Petition by plaintiff for discretionary review under G.S. 7A-31 denied 2 December 1980.
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 1 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 2 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 3 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 4 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 5 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 6 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 7 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 8 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 9 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 10 of 11
Case 1:07-cv-03531-CM-DCF Document 19 Filed 07/22/2008 Page 11 of 11
**EXHIBIT
      32.1**








In
      connection with the quarterly report of Berry Plastics Holding Corporation
      (the
“Registrant”) on Form 10-Q for the quarter ended March 31, 2007, as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I, Ira
      G. Boots, the President and Chief Executive Officer of the Registrant, certify,
      pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934, as amended; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Registrant.











/s/
      Ira G. Boots


Ira
      G.
      Boots


President
      and Chief Executive Officer





Date:  May
      15,
      2007
[Federal Register Volume 72, Number 189 (Monday, October 1, 2007)]
[Notices]
[Page 55787]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-4816]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel, Study Section Conflict Review of 
Applications.
    Date: October 11, 2007.
    Time: 8:30 a.m. to 9:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza Washington DC/Silver Spring, 8777 Georgia 
Ave., Silver Springs, MD 20910.
    Contact Person: Katrina L. Foster, PhD, Scientific Review 
Administrator, National Inst on Alcohol Abuse & Alcoholism, National 
Institutes of Health, 5635 Fishers Lane, Rm. 3037, Rockville, MD 
20852 301-443-3037, <a href="/cdn-cgi/l/email-protection#b2d9d3c6c0dbdcd3f2dfd3dbde9cdcdbda9cd5ddc4"><span class="__cf_email__" data-cfemail="751e1401071c1b143518141c195b1b1c1d5b121a03">[email protected]</span></a>.
    This notice is being submitted late due to conflict of interest 
that arose; making it necessary to review applications in a SEP 
(EE97).

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants, National Institutes of Health, HHS)

    Dated: September 24, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4816 Filed 9-28-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CERTIFICATION
   2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;
 4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
   Date: August 10, 2011
    /s/ Gerard M. Hayden, Jr.Gerard M. Hayden, Jr.Chief Financial Officer
[Federal Register Volume 70, Number 230 (Thursday, December 1, 2005)]
[Notices]
[Page 72144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23526]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration


Notice of Intent To Rule on Request To Release Airport Property 
at Shawnee Regional Airport, Shawnee, OK

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of request to release airport property.

-----------------------------------------------------------------------

SUMMARY: FAA proposes to rule and invites public comment on the release 
of land at Shawnee Regional Airport under the provisions of Title 49 of 
US Code, Section 47153.

DATES: Comments must be received on or before January 2, 2006.

ADDRESSES: Comments on this application may be mailed or delivered to 
the FAA at the following address: Mr. Edward N. Agnew, Manager, 
Airports Development Office, Federal Aviation Administration, Southwest 
Region, Airports Division, Arkansas/Oklahoma Airports Development 
Office, ASW-630, Fort Worth, Texas 76193-0630.
    In addition, one copy of any comments submitted to the FAA must be 
mailed or delivered to Mr. James C. Collard, City Manager, at the 
following address: PO Box 1448, Shawnee, OK 74802-1448.

FOR FURTHER INFORMATION CONTACT: Donald C. Harris, Senior Program 
Manager, Federal Aviation Administration, Arkansas/Oklahoma Airports 
Development Office, ASW-631, 2601 Meacham Blvd., Fort Worth, Texas 
76193-0630.
    The request to release property may be reviewed in person at this 
same location.

SUPPLEMENTARY INFORMATION: The FAA invites public comment on the 
request to release property at the Shawnee Regional Airport under the 
provisions of the Act.
    On November 23, 2005, the FAA determined that the request submitted 
by the City of Shawnee to release property at Shawnee Regional Airport 
met the procedural requirements of Federal Aviation Regulation Part 
155. The FAA may approve the request, in whole or in part, no later 
than January 5, 2006.
    The following is a brief overview of the request: The Shawnee 
Airport Authority requests the release of 8.2 acres of airport 
property. The sale is estimated to provide $156,800.00 to allow 
construction of an early childhood development center for the City of 
Shawnee. Any person may inspect the request in person at the FAA office 
listed above under FOR FURTHER INFORMATION CONTACT.
    In addition, any person may, upon request, inspect the application, 
notice and other documents germane to the application in person at the 
Shawnee Regional Airport.

    Issued in Fort Worth, Texas, on November 23, 2005.
Kelvin L. Solco,
Manager, Airports Division.
[FR Doc. 05-23526 Filed 11-30-05; 8:45 am]
BILLING CODE 4910-13-M
**Exhibit32.1**

**FORM 10-Q**

**Section 1350Certifications**

**Quarterended March 31, 2007**

I, Herbert Lindo,Chairman, President and Principal Financial Officer of Kenilworth SystemsCorporation (the “Company”), certify, pursuant to Section 906 of theSarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of myknowledge:

(1)     the Quarterly Report onForm 10-Q of the Company for the third quarter ended March 31, 2007 (the “Report”)fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));and

(2)     the information containedin the Report fairly presents, in all material respects, the financialcondition and results of operations of the Company.

Dated:   May10, 2007
|        | /s/ Herbert Lindo                                              |   |
|--------|----------------------------------------------------------------|--------|
|   | Herbert Lindo                                                  |
|   | Chairman, Chief Executive Officer and Chief  Financial Officer |

 

----
#### STARMOUNT CO. v. CITY OF GREENSBORO

No. 209 PC.

Case below: 41 N.C. App. 591.

Petition by defendant for discretionary review under G.S. 7A-31 denied 10 September 1979.
|     |                                                                                                                       |
|-----|-----------------------------------------------------------------------------------------------------------------------|
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |

|     |                                                                                                                                                      |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|        |
|--------|
|        |  |  |
| Date:  | May 5, 2011 |   |
|   |   | /s/ Robert F. Schneider |
|   |   | ROBERT F. SCHNEIDERExecutive Vice President,Chief Financial Officer |